Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Reilly

Showing results (551-560 of 605) with videos related to

Pageof 61
Sort By:
Cancer Research|July 26, 2000
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic miceR T Reilly, M B Gottlieb, A M Ercolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2012
Improving survival trends in primary myelofibrosis: an international studyFrancisco Cervantes, Brigitte Dupriez, Francesco Passamonti, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 19, 2002
Metabolic and appetite responses to prolonged walking under three isoenergetic dietsP N Ainslie, K Abbas, I T Campbell, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Blood|November 8, 2008
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentFrancisco Cervantes, Brigitte Dupriez, Arturo Pereira, et al.
British Journal of Haematology|November 25, 2000
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk groupF M Abu-Duhier, A C Goodeve, G A Wilson, et al.
Oncogene|May 23, 2012
Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progressionP T Reilly, W L Teo, M J Low, et al.
Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.
Advances in Therapy|November 13, 2020
A Comprehensive Review of Alternative Therapies for the Management of Chronic Pain Patients: Acupuncture, Tai Chi, Osteopathic Manipulative Medicine, and Chiropractic CareIvan Urits, Ruben H Schwartz, Vwaire Orhurhu, et al.
Nature|January 28, 2014
ANP32E is a histone chaperone that removes H2A.Z from chromatinArnaud Obri, Khalid Ouararhni, Christophe Papin, et al.
Pageof 61

Showing results (551-560 of 605) with videos related to

Sort By:
Pageof 61
Cancer Research|July 26, 2000
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic miceR T Reilly, M B Gottlieb, A M Ercolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2012
Improving survival trends in primary myelofibrosis: an international studyFrancisco Cervantes, Brigitte Dupriez, Francesco Passamonti, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 19, 2002
Metabolic and appetite responses to prolonged walking under three isoenergetic dietsP N Ainslie, K Abbas, I T Campbell, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Blood|November 8, 2008
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentFrancisco Cervantes, Brigitte Dupriez, Arturo Pereira, et al.
British Journal of Haematology|November 25, 2000
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk groupF M Abu-Duhier, A C Goodeve, G A Wilson, et al.
Oncogene|May 23, 2012
Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progressionP T Reilly, W L Teo, M J Low, et al.
Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.
Advances in Therapy|November 13, 2020
A Comprehensive Review of Alternative Therapies for the Management of Chronic Pain Patients: Acupuncture, Tai Chi, Osteopathic Manipulative Medicine, and Chiropractic CareIvan Urits, Ruben H Schwartz, Vwaire Orhurhu, et al.
Nature|January 28, 2014
ANP32E is a histone chaperone that removes H2A.Z from chromatinArnaud Obri, Khalid Ouararhni, Christophe Papin, et al.
Pageof 61